yttrium radioisotopes has been researched along with Renal Insufficiency in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilha, SC; Constantin, V; Covic, A; Matovic, M; Nistor, I; Simona, V; Stefanescu, C; Stolniceanu, CR | 1 |
| Emami, Z; Khamseh, ME; Maghsoomi, Z; Malboosbaf, R; Malek, M | 1 |
| Hubalewska-Dydejczyk, A; Królicki, L; Kunikowska, J; Mikołajczak, R; Pawlak, D; Sowa-Staszczak, A | 1 |
| Bartolomei, M; Bodei, L; Caracciolo, M; Chinol, M; Cremonesi, M; Grana, C; Mäcke, HR; Paganelli, G; Rocca, P; Zoboli, S | 1 |
| Cohen, EP; Moulder, JE; Robbins, ME | 1 |
2 review(s) available for yttrium radioisotopes and Renal Insufficiency
| Article | Year |
|---|---|
Nephrotoxicity/renal failure after therapy with 90Yttrium- and 177Lutetium-radiolabeled somatostatin analogs in different types of neuroendocrine tumors: a systematic review.
Topics: Humans; Isotope Labeling; Kidney; Lutetium; Neuroendocrine Tumors; Radioisotopes; Renal Insufficiency; Somatostatin; Yttrium Radioisotopes | 2020 |
Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.
Topics: Carcinoma, Neuroendocrine; Hematologic Diseases; Humans; Iodine Radioisotopes; Octreotide; Organometallic Compounds; Radiation Injuries; Radiation Tolerance; Radiopharmaceuticals; Renal Insufficiency; Thyroid Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2021 |
2 trial(s) available for yttrium radioisotopes and Renal Insufficiency
| Article | Year |
|---|---|
Nephrotoxicity after PRRT - still a serious clinical problem? Renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATATE and 90Y/177Lu-DOTATATE.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Kidney; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Renal Insufficiency; Yttrium Radioisotopes | 2013 |
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study.
Topics: Adult; Aged; Amino Acids; Biomarkers, Tumor; Blood Platelets; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Hemoglobins; Humans; Kidney; Lymphocytes; Male; Maximum Tolerated Dose; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Octreotide; Radiation-Protective Agents; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Renal Insufficiency; Vomiting; Yttrium Radioisotopes | 2003 |
1 other study(ies) available for yttrium radioisotopes and Renal Insufficiency
| Article | Year |
|---|---|
Radiation nephropathy caused by yttrium 90.
Topics: Dose-Response Relationship, Radiation; Humans; Radiation Injuries; Radioimmunotherapy; Renal Insufficiency; Yttrium Radioisotopes | 2001 |